Company Filing History:
Years Active: 2019-2023
Title: The Innovative Contributions of Rajesh Narwal
Introduction
Rajesh Narwal is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies for cancer treatment. With a total of 5 patents to his name, Narwal's work has the potential to impact the lives of many patients suffering from various forms of cancer.
Latest Patents
Among his latest patents, Narwal has developed methods for treating B7-H1-expressing tumors. This includes the administration of MEDI4736 or an antigen-binding fragment thereof. Additionally, he has worked on anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer, which involves administering MEDI4736 or an antigen-binding fragment thereof alongside tremelimumab or an antigen-binding fragment thereof.
Career Highlights
Rajesh Narwal is currently associated with MedImmune Limited, a leading biotechnology company. His work at MedImmune has allowed him to focus on innovative solutions for cancer treatment, contributing to the advancement of medical science.
Collaborations
Throughout his career, Narwal has collaborated with notable colleagues such as Paul Robbins and David Fairman. These collaborations have fostered a productive environment for research and development in the field of oncology.
Conclusion
Rajesh Narwal's contributions to cancer treatment through his innovative patents and collaborations highlight his importance in the field of biotechnology. His work continues to pave the way for new therapeutic options for patients in need.